Bartels S, Vogtmann J, Schipper E, Busche G, et al. Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression. Eur J Haematol 2021;106:520-528.
PMID: 33460496